Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers, Lancet Neurol, vol.12, pp.207-216, 2013. ,
Diagnostic accuracy of (18)F amyloid PET tracers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis, Eur. J. Nucl. Med. Mol. Imaging, vol.43, pp.374-385, 2016. ,
Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography, J. Neurosci. Off. J. Soc. Neurosci, vol.27, pp.10957-10968, 2007. ,
Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain, J. Neurosci. Off. J. Soc. Neurosci, vol.25, pp.10598-10606, 2005. ,
Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswePS1dE9 mouse models of Alzheimer disease, J. Nucl. Med. Off. Publ. Soc. Nucl. Med, vol.54, pp.1434-1441, 2013. ,
In vivo evaluation of amyloid deposition and brain glucose metabolism of 5XFAD mice using positron emission tomography, Neurobiol. Aging, vol.34, pp.1790-1798, 2013. ,
Limitations of small animal PET imaging with [18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer's disease, Mol. Imaging Biol. MIB Off. Publ. Acad. Mol. Imaging, vol.11, pp.236-240, 2009. ,
PET imaging with [18F]AV-45 in an APP/PS1-21 murine model of amyloid plaque deposition, Neurobiol. Aging, vol.33, pp.2561-2571, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01853953
In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe, Nat. Biotechnol, vol.23, pp.577-583, 2005. ,
Multiphoton in vivo imaging of amyloid in animal models of Alzheimer's disease, Neuropharmacology, vol.59, pp.268-275, 2010. ,
In vivo imaging biomarkers in mouse models of Alzheimer's disease: are we lost in translation or breaking through?, Int. J. Alzheimers Dis, p.2010, 2010. ,
In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent, Magn. Reson. Med, vol.52, pp.1263-1271, 2004. ,
In vivo measurement of plaque burden in a mouse model of Alzheimer's disease, J. Magn. Reson. Imaging JMRI, vol.24, pp.1011-1017, 2006. ,
Comparison of amyloid plaque contrast generated by T2-weighted, T2*-weighted, and susceptibilityweighted imaging methods in transgenic mouse models of Alzheimer's disease, Magn. Reson. Med, vol.61, pp.1158-1164, 2009. ,
Characterization of in vivo MRI detectable thalamic amyloid plaques from APP/PS1 mice, Neurobiol. Aging, vol.30, pp.41-53, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00320356
Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy, Proc. Natl. Acad. Sci. USA, vol.96, pp.14079-14084, 1999. ,
In vivo visualization of senile-plaque-like pathology in Alzheimer's disease patients by MR microscopy on a 7T system, J. Neuroimaging Off. J. Am. Soc. Neuroimaging, vol.18, pp.125-129, 2008. ,
MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice, J. Magn. Reson. Imaging JMRI, vol.29, pp.997-1007, 2009. ,
Histological co-localization of iron in Abeta plaques of PS/APP transgenic mice, Neurochem. Res, vol.30, pp.201-205, 2005. ,
Senile plaques do not induce susceptibility effects in T2*-weighted MR microscopic images, NMR Biomed, vol.15, pp.197-203, 2002. ,
Activated iron-containing microglia in the human hippocampus identified by magnetic resonance imaging in Alzheimer disease, Neurobiol. Aging, vol.36, pp.2483-2500, 2015. ,
Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging, Neurobiol. Dis, vol.11, pp.315-329, 2002. ,
19F and 1H MRI detection of amyloid beta plaques in vivo, Nat. Neurosci, vol.8, pp.527-533, 2005. ,
A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice, Neurobiol. Aging, vol.29, pp.836-847, 2008. ,
Detection of amyloid plaques targeted by bifunctional USPIO in Alzheimer's disease transgenic mice using magnetic resonance microimaging, PloS One, vol.8, p.57097, 2013. ,
Gadolinium-staining reveals amyloid plaques in the brain of Alzheimer's transgenic mice, Neurobiol. Aging, vol.33, pp.1533-1544, 2012. ,
Fast in vivo imaging of amyloid plaques using ?-MRI Gd-staining combined with ultrasound-induced blood-brain barrier opening, NeuroImage, vol.79, pp.288-294, 2013. ,
Passive staining: a novel ex vivo MRI protocol to detect amyloid deposits in mouse models of Alzheimer's disease, Magn. Reson. Med, vol.55, pp.687-693, 2006. ,
In vivo detection of amyloid plaques by Gadolinium-stained MRI can be used to demonstrate the efficacy of an anti-amyloid immunotherapy, Front. Aging Neurosci, vol.8, p.55, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-02155734
Micro-MRI study of cerebral aging: ex vivo detection of hippocampal subfield reorganization, microhemorrhages and amyloid plaques in mouse lemur primates, PloS One, vol.8, p.56593, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01407046
MRI detection of prion protein plaques in variant Creutzfeldt-Jakob disease, Neurology, vol.84, pp.1498-1499, 2015. ,
Cerebrovascular disease in ageing and Alzheimer's disease, Acta Neuropathol. (Berl.), vol.131, pp.645-658, 2016. ,
MR Imaging Features of Amyloid-Related Imaging Abnormalities, Am. J. Neuroradiol, vol.34, pp.1958-1965, 2013. ,
Noninvasive magnetic resonance imaging detection of cerebral amyloid angiopathy-related microvascular alterations using superparamagnetic iron oxide particles in APP transgenic mouse models of Alzheimer's disease: application to passive Abeta immunotherapy, J. Neurosci, vol.31, pp.1023-1031, 2011. ,
Magnetic resonance imaging detection and time course of cerebral microhemorrhages during passive immunotherapy in living amyloid precursor protein transgenic mice, J. Pharmacol. Exp. Ther, vol.335, pp.580-588, 2010. ,
Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome, Arch. Pathol. Lab. Med, vol.125, pp.489-492, 2001. ,
Intraneuronal Abeta42 accumulation in human brain, Am. J. Pathol, vol.156, pp.15-20, 2000. ,
Intracellular amyloid-beta in Alzheimer's disease, Nat. Rev. Neurosci, vol.8, pp.499-509, 2007. ,
In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice, J. Neurosci. Off. J. Soc. Neurosci, vol.25, pp.10041-10048, 2005. ,
High-field MRI of single histological slices using an inductively coupled, self-resonant microcoil: application to ex vivo samples of patients with Alzheimer's disease, NMR Biomed, vol.24, pp.351-357, 2011. ,
Iron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion, Prog. Neurobiol, vol.94, pp.296-306, 2011. ,
Regional differences in MRI detection of amyloid plaques in AD transgenic mouse brain, NeuroImage, vol.54, pp.113-122, 2011. ,
, Scientific RepoRts |, vol.7
MR microscopy of human amyloid-? deposits: characterization of parenchymal amyloid, diffuse plaques, and vascular amyloid, J. Alzheimers Dis. JAD, vol.34, pp.1037-1049, 2013. ,
Time sequence of maturation of dystrophic neurites associated with Abeta deposits in APP/PS1 transgenic mice, Exp. Neurol, vol.184, pp.247-263, 2003. ,
Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase, Hum. Mol. Genet, vol.13, pp.159-170, 2004. ,
Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease, Neurobiol. Dis, vol.24, pp.516-524, 2006. ,
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology, Proc. Natl. Acad. Sci. USA, vol.94, pp.13287-13292, 1997. ,
Neuron loss in APP transgenic mice, Nature, vol.395, pp.755-756, 1998. ,
Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor, J. Biol. Chem, vol.279, pp.20296-20306, 2004. ,
Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction, Neuron, vol.39, pp.409-421, 2003. ,
The mouse brain in stereotaxic coordinates, 2001. ,
Morphological and carbogen-based functional MRI of a chemically induced liver tumor model in mice, Magn. Reson. Med, vol.50, pp.522-530, 2003. ,
cFos immunoreactivity is enhanced with biotin amplification, J. Histochem. Cytochem. Off. J. Histochem. Soc, vol.42, pp.1635-1642, 1994. ,
Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease, Neurobiol. Dis, vol.22, pp.199-208, 2006. ,
Image to ImageJ: 25 years of image analysis, Nat. Methods, vol.9, pp.671-675, 2012. ,